Drugs / AD17137
last change Jul 2014 re-read 3 minutes ago

AD17137

Developed for
actinic keratosis
Investigated by
Assuta Hospital Systems

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01921907 Jul 2013 → Jun 2014 actinic keratosis Assuta Hospital Systems Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AD17137 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01921907 ↗
Route Topical “A topical treatment applied twice daily for 4 weeks” NCT01921907 ↗